Evidence map›Paper›PMID 27058240›Full record

ArticlePloS one2016

Extra-Esophageal Pepsin from Stomach Refluxate Promoted Tonsil Hypertrophy.

Jin Hyun Kim, Han-Sin Jeong, Kyung Mi Kim, Ye Jin Lee, Myeong Hee Jung, Jung Je Park, Jin Pyeong Kim, Seung Hoon Woo

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Observational
  2. Causal association of gastroesophageal reflux disease with chronic sinusitis and chronic disease of the tonsils and adenoids.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  3. Article
  4. Review
  5. Effects of acids, pepsin, bile acids, and trypsin on laryngopharyngeal reflux diseases: physiopathology and therapeutic targets.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jin Hyun KimBiomedical Research Institute, Gyeongsang National University Hospital, Jinju, Gyeongsangnamdo, Korea.
Han-Sin JeongDepartment of Otorhinolaryngology-Head and Neck Surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.
Kyung Mi KimBiomedical Research Institute, Gyeongsang National University Hospital, Jinju, Gyeongsangnamdo, Korea.
Ye Jin LeeBiomedical Research Institute, Gyeongsang National University Hospital, Jinju, Gyeongsangnamdo, Korea.
Myeong Hee JungBiomedical Research Institute, Gyeongsang National University Hospital, Jinju, Gyeongsangnamdo, Korea.
Jung Je ParkDepartment of Otolaryngology, Gyeongsang National University Hospital, Jinju, Gyeongsangnamdo, Korea.
Jin Pyeong KimDepartment of Otolaryngology, Gyeongsang National University Hospital, Jinju, Gyeongsangnamdo, Korea.
Seung Hoon WooDepartment of Otolaryngology, Gyeongsang National University Hospital, Jinju, Gyeongsangnamdo, Korea.
Gyeongsang National University Hospital · KRSungkyunkwan University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGastroesophageal reflux is associated with numerous pathologic conditions of the upper aerodigestive tract. Gastric pepsin within reflux contributes to immunologic reactions in the tonsil. In this study, we aimed to find the relationships between pepsin and tonsillar hypertrophy. METHODS AND FINDING: We explored the notion whether tonsillar hypertrophy was due to pepsin-mediated gastric reflux in tonsil hypertrophy. Fifty-four children with tonsil hypertrophy and 30 adults with tonsillitis were recruited before surgical treatment. Blood and tonsil tissues from each patient were harvested for analysis of changes in lymphocyte and macrophage numbers coupled with histological and biochemical analysis. Pepsin was expressed at different levels in tonsil tissues from each tonsillar hypertrophy. Pepsin-positive cells were found in the crypt epithelium, surrounding the lymphoid follicle with developing fibrosis, and also surrounding the lymphoid follicle that faced the crypt. And also, pepsin staining was well correlated with damaged tonsillar squamous epithelium and TGF-β1 and iNOS expression in the tonsil section. In addition, pepsin and TGF-β1-positive cells were co-localized with CD68-positive cells in the crypt and surrounding germinal centers. In comparison of macrophage responsiveness to pepsin, peripheral blood mononuclear cells (PBMNCs) were noticeably larger in the presence of activated pepsin in the child group. Furthermore, CD11c and CD163-positive cells were significantly increased by activated pepsin. However, this was not seen for the culture of PBMNCs from the adult group.

conclusionsThe lymphocytes and monocytes are in a highly proliferative state in the tonsillar hypertrophy and associated with increased expression of pro-inflammatory factors as a result of exposure to stomach reflux pepsin.

Indexed as

AdultBlotting, WesternCell MovementCells, CulturedCell SurvivalChildChild, PreschoolFemaleFluorescent Antibody TechniqueGastrointestinal AgentsHumansHypertrophyImmunoenzyme TechniquesImmunoprecipitationMacrophagesMaleGastrointestinal AgentsPepsin ARNA, Messenger

Identifiers

PMID27058240
PMCPMC4825923
OpenAlexW2316760541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.